CAS RN: 1897379-34-8
(2S)-2-[3-[4-(Octyloxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-1-pyrrolidinecarboximidamide hydrochloride
Product Availability
Choose a grade to view its available package options.
5 package records3 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250121 |
100mg |
Out of stock |
| Inquiry |
| Batchno.20250708 |
10mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250426 |
25mg |
In stock |
Shanghai | Inquiry |
| Batchno.20251021 |
50mg |
Out of stock |
| Inquiry |
| Batchno.20250611 |
5mg |
In stock |
Shanghai | Inquiry |
-
Product code:
starshine_CAS1897379-34-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1897379-34-8 / (2S)-2-[3-[4-octoxy-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide;hydrochloride
Standard CAS: 1897379-34-8
Multi CAS: No
Basic Information
CAS
1897379-34-8
Multi CAS
No
Molecular Formula
C22H31ClF3N5O2
Molecular Weight
490.000000
Exact Mass
489.211837
SMILES
CCCCCCCCOC1=C(C=C(C=C1)C2=NOC(=N2)[C@@H]3CCCN3C(=N)N)C(F)(F)F.Cl
InChI
InChI=1S/C22H30F3N5O2.ClH/c1-2-3-4-5-6-7-13-31-18-11-10-15(14-16(18)22(23,24)25)19-28-20(32-29-19)17-9-8-12-30(17)21(26)27;/h10-11,14,17H,2-9,12-13H2,1H3,(H3,26,27);1H/t17-;/m0./s1
InChIKey
YIGAQKBPLMSWOD-LMOVPXPDSA-N
Computed Properties
Structural Parameters
Heavy atom count
33
Aromatic heavy atom count
11
Fraction Csp3
0.59
Rotatable bonds
10
H-bond acceptors
5
H-bond donors
2
Molar refractivity
121.45
TPSA
101.26
LogP / Solubility
WLOGP
5.95
MLOGP
5.27
XLogP3
5.95
Consensus LogP
5.72
Log S (ESOL)
-6.21
Class (ESOL)
Insoluble
Log S (Ali)
-7.87
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.98
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.49
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3